×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • ORBIMED ADVISORS LLC (Data extracted from 13F, 13D, 13G and Form 4)

ORBIMED ADVISORS LLC

AUM: $18.21 B
13-F Portfolio Value: $4.00 B
Last 13-F Filed: Q2 2025
Concentration in top 10: 48.84%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
SLRNACELYRIN INC-4,001,711Exited13F
IVVDINVIVYD INC-933,500Exited13F
AMGNAMGEN INC-44,200Exited13F
BCAXBICARA THERAPEUTICS INC-298,301Exited13F
PHGEBIOMX INC-1,787,767Exited13F
CRDFCARDIFF ONCOLOGY INC-573,884Exited13F
CBLLCERIBELL INC-112,500Exited13F
FATEFATE THERAPEUTICS INC-1,680,580Exited13F
GILDGILEAD SCIENCES INC-197,500Exited13F
TILINSTIL BIO INC-116,785Exited13F
IONSIONIS PHARMACEUTICALS INC-2,540,136Exited13F
NKTXNKARTA INC-821,400Exited13F
PFEPFIZER INC-3,850,200Exited13F
PFEPFIZER INC (Call)-500,000Exited13F
NXTCNEXTCURE INC-1,141,200Exited13F
RAPTRAPT THERAPEUTICS INC-13,135,260Exited13F
XBISPDR SER TR (Call)-100,000Exited13F
SRRKSCHOLAR ROCK HLDG CORP-151,800Exited13F
SWTXSPRINGWORKS THERAPEUTICS INC-950,200Exited13F
SWTXSPRINGWORKS THERAPEUTICS INC (Call)-172,600Exited13F
GPCRSTRUCTURE THERAPEUTICS INC (Call)-150,000Exited13F
TNGXTANGO THERAPEUTICS INC-550,000Exited13F
VSTMVERASTEM INC-2,862,448Exited13F
VERAVERA THERAPEUTICS INC-481,065Exited13F
XTNTXTANT MED HLDGS INC-73,114,592Exited13F
XFORX4 PHARMACEUTICALS INC-6,776,515Exited13F
KMTSKESTRA MED TECHNOLOGIES LTD-250,000Exited13F